AVITA Medical (RCEL) Net Margin Growth (3y) (2021 - 2025)
AVITA Medical (RCEL) Net Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,018.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1,978.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 399.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -22,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22,798.00 |
| Sep 30, 2025 | -1,658.00 |
| Mar 31, 2025 | 4,989.00 |
| Sep 30, 2024 | -1,904.00 |
| Jun 30, 2024 | -4,511.00 |
| Mar 31, 2024 | -9,961.00 |
| Dec 31, 2023 | 6,077.00 |
| Sep 30, 2023 | 13,827.00 |
| Jun 30, 2023 | 24,474.00 |
| Mar 31, 2023 | 30,074.00 |
| Dec 31, 2022 | 54,870.00 |
| Sep 30, 2022 | 4,826.00 |
| Mar 31, 2022 | 23,600.00 |
| Sep 30, 2021 | 180,751.00 |